Arrowhead Pharma Stock (NASDAQ: ARWR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.250M |
Day Range | - - - |
52 Wk Range | 20.670 - 42.480 |
Market Cap | $2.710B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 8.4% |
Days to Cover | 10.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arrowhead Pharma (NASDAQ: ARWR) through any online brokerage.
Other companies in Arrowhead Pharma’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for Arrowhead Pharma (NASDAQ: ARWR) was reported by HC Wainwright & Co. on Thursday, February 8, 2024. The analyst firm set a price target for 90.00 expecting ARWR to rise to within 12 months (a possible 311.52% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Arrowhead Pharma (NASDAQ: ARWR) is $21.87 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Arrowhead Pharma.
Arrowhead Pharma’s Q2 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Arrowhead Pharma.
Arrowhead Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.